Endometrial Serous Adenocarcinoma

2

Review clinical trials related to Endometrial Serous Adenocarcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers

This study is to find out how well liquid biopsies work as a non-invasive alternative to other methods of finding cancer cells (such as a tissue biopsy) in patients with endometrial cancer. A liquid biopsy is a blood test that may be able to find cancer cells. Collecting and storing samples of blood and tissue from patients with endometrial cancer to study in the laboratory may help doctors learn how the cells in the blood may change during treatment for uterine cancer.

Participants needed: 1,000
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: M.D. Anderson Cancer CenterUpdated: May 6, 2026Locations: 1
Eligibility criteria

Women age 18 years and older [+3]

Status: Recruiting

Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

This randomized phase III trial studies short course vaginal cuff brachytherapy to see how well it works compared with standard of care vaginal cuff brachytherapy in treating participants with stage I-II endometrial cancer. Short course vaginal cuff brachytherapy, also known as internal radiation therapy, uses (over a shorter period) radioactive material placed directly into or near a tumor in the upper portion of the vagina to kill tumor cells. After completion of cohort 1 (108 participants), the protocol was expended to add a second cohort of 80 additional participants, and re-opened study recruitment.

Participants needed: 188
Trial details
Phase: Phase 3Biological sex: AllType: InterventionalSponsor: University of UtahUpdated: Dec 12, 2025Locations: 5
Eligibility criteria

Stage IA, grade 1 with LVSI, 2, 3 [+7]

Stages of endometrial carcinoma other than described. [+2]